InfuSystem Holdings, Inc. (INFU) on Decifer

Decifer ranks INFU number 102 of 274 tracked names on durable business quality.

Why it ranks here

• It earns solid returns on the money it puts to work, around 9% and those returns have been improving and it turns most of its profit into real cash.
• Revenue is growing about 6% a year and profits grew 191% over the past year.
• It keeps a high share of every sale as profit, and that has stayed steady over the years, a sign of real pricing power, with profitability widening as it grows.
• It is riding an active market tailwind and has the balance sheet to fund its growth.
• It is not watering down its owners with new shares and it returns cash to shareholders.
• Profits up 191 percent and momentum of 22 out of 35 are lively but returns around 9 percent and no funded role keep it in the middle.

The current read

The evidence on INFU lines up on the supportive side: a live market force supports this name through its theme connection. The independent signals we track are telling the same story.

Themes

• Robotic & Minimally-Invasive Intervention: Clinical and economic evidence favoring minimally invasive robotic and thrombectomy procedures is shifting procedure volumes and capital equipment budgets toward advanced interventional platforms.

Read the full INFU research brief · See all quality rankings

Intelligence data powered by Decifer. Not financial advice. For informational purposes only.